ORGO
Price:
$3.195
Market Cap:
$401.69M
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediat...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-01-05
Stock Exchange
NASDAQ
Ticker
ORGO
According to Organogenesis Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -63.90. This represents a change of -7.79% compared to the average of -69.30 of the last 4 quarters.
The mean historical PE Ratio of Organogenesis Holdings Inc. over the last ten years is -342.90. The current -63.90 PE Ratio has changed 1.76% with respect to the historical average. Over the past ten years (40 quarters), ORGO's PE Ratio was at its highest in in the March 2022 quarter at 2.82K. The PE Ratio was at its lowest in in the June 2016 quarter at -42046.88.
Average
-342.90
Median
0
Minimum
-2952.41
Maximum
108.54
Discovering the peaks and valleys of Organogenesis Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 381.83%
Maximum Annual PE Ratio = 108.54
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -2952.41
Year | PE Ratio | Change |
---|---|---|
2023 | 108.54 | 381.83% |
2022 | 22.53 | 78.96% |
2021 | 12.59 | -73.26% |
2020 | 47.07 | -526.44% |
2019 | -11.04 | 2.23% |
2018 | -10.80 | -96.43% |
2017 | -302.62 | -89.75% |
2016 | -2952.41 | -Infinity% |
The current PE Ratio of Organogenesis Holdings Inc. (ORGO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
47.89
5-year avg
35.94
10-year avg
-342.90
Organogenesis Holdings Inc.’s PE Ratio is less than Shuttle Pharmaceuticals Holdings, Inc. (-0.21), less than Mallinckrodt plc (-0.04), less than Lucy Scientific Discovery Inc. (-1.23), less than Alimera Sciences, Inc. (-20.50), less than Lifecore Biomedical, Inc. (35.87), less than RedHill Biopharma Ltd. (1.79), less than Taro Pharmaceutical Industries Ltd. (29.99), less than Collegium Pharmaceutical, Inc. (10.62), less than Adamis Pharmaceuticals Corporation (-0.67), less than Alpha Teknova, Inc. (-12.52), less than Guardion Health Sciences, Inc. (0.65), less than Petros Pharmaceuticals, Inc. (-0.27), less than Alkermes plc (14.49), less than Neurocrine Biosciences, Inc. (35.87), greater than Intra-Cellular Therapies, Inc. (-104.72), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Dynavax Technologies Corporation (81.84),
Company | PE Ratio | Market cap |
---|---|---|
-0.21 | $2.91M | |
-0.04 | $4.52M | |
-1.23 | $906.91K | |
-20.50 | $301.29M | |
35.87 | $279.89M | |
1.79 | $8.44M | |
29.99 | $1.62B | |
10.62 | $940.58M | |
-0.67 | $7.25M | |
-12.52 | $474.97M | |
0.65 | $4.35M | |
-0.27 | $2.89M | |
14.49 | $4.78B | |
35.87 | $13.86B | |
-104.72 | $9.07B | |
-11.74 | $2.21B | |
81.84 | $1.68B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organogenesis Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Organogenesis Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Organogenesis Holdings Inc.'s PE Ratio?
How is the PE Ratio calculated for Organogenesis Holdings Inc. (ORGO)?
What is the highest PE Ratio for Organogenesis Holdings Inc. (ORGO)?
What is the 3-year average PE Ratio for Organogenesis Holdings Inc. (ORGO)?
What is the 5-year average PE Ratio for Organogenesis Holdings Inc. (ORGO)?
How does the current PE Ratio for Organogenesis Holdings Inc. (ORGO) compare to its historical average?